SERB

Location

ILE DE FRANCE

Founded

1951-07-25

Website

https://serb.com

Risk Signals

33 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Business Litigation (1) Private Equity Buyouts (1)

Recent Articles about SERB

Live alerts from global media, monitored by Business Radar

Ex­clu­sive: Af­ter win­ning le­gal bat­tle, for­mer Phase­Bio in­vestor finds US buy­er for its PhI­II drug to re­verse Bril­in­ta

(endpts.com)

Ex­clu­sive: Af­ter win­ning le­gal bat­tle, for­mer Phase­Bio in­vestor finds US buy­er for its PhI­II drug to re­verse Bril­in­ta

Having wrangled control of a blood thinner reversal agent, SFJ Pharma has found a buyer for the drug. SERB Pharmaceuticals, a specialty pharma that vastly expanded its portfolio through several ...

Read more

Never miss a headline about SERB

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages